Atlas of Gastric Cancer Links Ferroptosis to Disease… : Oncology Times
An abstract is unavailable.
Related Articles
A Pioneering Journey in Radiation Oncology Inspired by Multidisciplinary Collaboration
Fueled by wanting to carry on his father’s legacy, Ralph R. Weichselbaum, MD, created his own mark on radiation therapy in oncologic care.
Evaluating the 2023 Standardized Letter of Recommendation… : JAAOS – Journal of the American Academy of Orthopaedic Surgeons
suffered from notable rank inflation ultimately requiring introduction of an updated SLOR for the 2023 to 2024 application cycle. The purpose of this study was…
New Advances in Waldenström Macroglobulinemia
Understanding Waldenström Macroglobulinemia, and genomic profiles influencing clinical presentation and treatment strategies.
Debate: What Is the Best Posttransplant Follow-Up – Maintenance vs Close Monitoring With Laboratory Testing
Panelists debate the best posttransplant follow-up approach for acute myeloid leukemia, weighing the benefits of maintenance therapy vs close monitoring with regular laboratory testing to…
Ohio State’s Update From the 2024 San Antonio Breast Cancer Symposium 02/01/2025
Breast cancer experts from Ohio State and invited speakers will bring you the latest insights and practical guidance as presented at the 2024 San Antonio…
Dr Riess on the Investigation of Ivonescimab in Advanced NSCLC
Jonathan Wesley Riess, MD, MS, discusses data from the phase 3 HARMONi-2 trial evaluating ivonescimab vs pembrolizumab in advanced NSCLC.
Community Practice Training During Fellowship Often Falls Short
A hematology fellow discusses findings from 2 surveys he coauthored, which sought to identify gaps in community practice training during hematology/oncology fellowship.
Options for MRD Testing Affect Patient Treatment Plan in Lung Cancer
Luis E. Raez, MD, discusses when minimal residual disease testing can be performed as an option for patients with lung cancer.
New Assessment Method for Upper Limb Function in Patients… : Spine
y of Background Data. We devised and evaluated the utility of a new assessment method called the 10 Coins Test, which is based on daily…
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation
Dr. Richard Pazdur for 25 years has overseen innovations in the treatment of deadly diseases at the agency.
